Abstract
Despite the increasing efforts to limit waste and avoid environmental contaminants, a large number of compounds using in the pharmaceutical field may have an ecotoxicological impact. Nevertheless, a complete overview of all possible ecotoxicological effects of pharmaceuticals is missing: that is especially true for chemical impurities. The lacking information regarding environmental behavior of impurities could be faced by computational techniques: the ability to predict the unknown toxicity of a compound can reduce uncertainties regarding possible negative effects on the environment of pharmaceutical impurities. In the current scenario, non-testing methods may answer to the requirement of assessing the ecotoxicological impact of chemicals in a more affordable way. For this purpose, in the first part of the review, definition and classification of chemical impurities are proposed, while in the second part, a description of four open-source computational tools (T.E.S.T., VEGA, LAZAR, and QSAR Toolbox) is provided after a brief survey of the computational methods. The paper also shows the advantages of combining individual test methods in order to increase confidence in the predictive results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sheldon RA (Delft U of T (Netherlands)) (1994) Consider the environmental quotient. CHEMTECH U S 24:3
Sheldon RA (2005) Green solvents for sustainable organic synthesis: state of the art. Green Chem 7:267–278. https://doi.org/10.1039/B418069K
Halling-Sørensen B, Nors Nielsen S, Lanzky PF et al (1998) Occurrence, fate and effects of pharmaceutical substances in the environment- a review. Chemosphere 36:357–393. https://doi.org/10.1016/S0045-6535(97)00354-8
Dietrich DR, Webb SF, Petry T (2002) Hot spot pollutants: pharmaceuticals in the environment. Toxicol Lett 131:1–3. https://doi.org/10.1016/S0378-4274(02)00062-0
Kot-Wasik A, Jakimska A, Śliwka-Kaszyńska M (2016) Occurrence and seasonal variations of 25 pharmaceutical residues in wastewater and drinking water treatment plants. Environ Monit Assess 188. https://doi.org/10.1007/s10661-016-5637-0
Ying G-G, Zhao J-L, Zhou L-J, Liu S (2013) Fate and occurrence of pharmaceuticals in the aquatic environment (surface water and sediment). In: Comprehensive Analytical Chemistry. Elsevier, pp 453–557
Ferrari B, Paxéus N, Giudice RL et al (2003) Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Saf 55:359–370. https://doi.org/10.1016/S0147-6513(02)00082-9
Barra Caracciolo A, Topp E, Grenni P (2015) Pharmaceuticals in the environment: biodegradation and effects on natural microbial communities. Rev J Pharm Biomed Anal 106:25–36. https://doi.org/10.1016/j.jpba.2014.11.040
aus der Beek T, Weber F-A, Bergmann A et al (2016) Pharmaceuticals in the environment-global occurrences and perspectives: pharmaceuticals in the global environment. Environ Toxicol Chem 35:823–835. https://doi.org/10.1002/etc.3339
Henschel K-P, Wenzel A, Diedrich M, Fliedner A (1997) Environmental hazard assessment of pharmaceuticals. Regul Toxicol Pharmacol 25:220–225. https://doi.org/10.1006/rtph.1997.1102
Cleuvers M (2003) Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142:185–194. https://doi.org/10.1016/S0378-4274(03)00068-7
Chatzitakis A, Berberidou C, Paspaltsis I et al (2008) Photocatalytic degradation and drug activity reduction of chloramphenicol. Water Res 42:386–394. https://doi.org/10.1016/j.watres.2007.07.030
Méndez-Arriaga F, Esplugas S, Giménez J (2008) Photocatalytic degradation of non-steroidal anti-inflammatory drugs with TiO2 and simulated solar irradiation. Water Res 42:585–594. https://doi.org/10.1016/j.watres.2007.08.002
Hughes Mike, Health JBS of P. The principles of humane experimental technique: preface. In: Johns Hopkins Bloom. Sch. Public Health. http://altweb.jhsph.edu/pubs/books/humane_exp/addendum. Accessed 28 May 2019
Abraham J (2009) International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. In: Brouder A, Tietje C (eds) Handbook of transnational economic governance regimes. Brill, pp 1041–1054
Prat D, Pardigon O, Flemming H-W et al (2013) Sanofi’s solvent selection guide: a step toward more sustainable processes. Org Process Res Dev 17:1517–1525. https://doi.org/10.1021/op4002565
Fontaine N, Reynders D (2001) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the community code relating to medicinal products for human use. Off J Eur Commun L 311:67–128
Convention USP (2009) USP NF 2009. United States Pharmacopeial Convention. https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/usp-nf-notices/usp38_nf33_gn.pdf
Alsante KM, et al (2001) Isolation and identification of process related impurities and degradation products from pharmaceutical drug candidates, Part I. Am Pharm Rev 4:70–78
Mangiatordi GF, Alberga D, Altomare CD et al (2016) Mind the gap! A journey towards computational toxicology. Mol Inform 35:294–308. https://doi.org/10.1002/minf.201501017
Nicolotti O, Benfenati E, Carotti A et al (2014) REACH and in silico methods: an attractive opportunity for medicinal chemists. Drug Discov Today 19:1757–1768. https://doi.org/10.1016/j.drudis.2014.06.027
Gissi A, Mangiatordi GF, Sobański T et al (2017) Nontest methods for REACH legislation. In: Comprehensive medicinal chemistry III. Elsevier, pp 472–490
Todeschini R, Consonni V (2008) Handbook of molecular descriptors. John Wiley & Sons, Weinheim/New York
McKinney JD, Richard A, Waller C et al (2000) The practice of structure activity relationships (SAR) in toxicology. Toxicol Sci 56:8–17. https://doi.org/10.1093/toxsci/56.1.8
Cronin Mark TD, Jaworska Joanna S, Walker John D et al (2003) Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environ Health Perspect 111:1391–1401. https://doi.org/10.1289/ehp.5760
Cronin Mark TD, Walker John D, Jaworska Joanna S et al (2003) Use of QSARs in international decision-making frameworks to predict ecologic effects and environmental fate of chemical substances. Environ Health Perspect 111:1376–1390. https://doi.org/10.1289/ehp.5759
Gissi A, Nicolotti O, Carotti A et al (2013) Integration of QSAR models for bioconcentration suitable for REACH. Sci Total Environ 456–457:325–332. https://doi.org/10.1016/j.scitotenv.2013.03.104
Gissi A, Lombardo A, Roncaglioni A et al (2015) Evaluation and comparison of benchmark QSAR models to predict a relevant REACH endpoint: the bioconcentration factor (BCF). Environ Res 137:398–409. https://doi.org/10.1016/j.envres.2014.12.019
Gissi A, Gadaleta D, Floris M et al (2014) An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes. ALTEX - Altern Anim Exp 31:23–36. https://doi.org/10.14573/altex.1305221
Dearden JC, Barratt MD, Benigni R, et al (1997) The development and validation of expert systems for predicting toxicity: the report and recommendations of an ECVAM/ECB workshop (ECVAM Workshop 24)
Ashby J, Tennant RW (1988) Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. Mutat Res Toxicol 204:17–115. https://doi.org/10.1016/0165-1218(88)90114-0
Mentzas G (1994) A functional taxonomy of computer-based information systems. Int J Inf Manag 14:397–410. https://doi.org/10.1016/0268-4012(94)90015-9
Benfenati E (2016) In Silico methods for predicting drug toxicity. Springer New York, New York
Pizzo F, Gadaleta D, Lombardo A et al (2015) Identification of structural alerts for liver and kidney toxicity using repeated dose toxicity data. Chem Cent J 9:62. https://doi.org/10.1186/s13065-015-0139-7
Dobo KL, Greene N, Cyr MO et al (2006) The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development. Regul Toxicol Pharmacol 44:282–293. https://doi.org/10.1016/j.yrtph.2006.01.004
Floris M, Manganaro A, Nicolotti O et al (2014) A generalizable definition of chemical similarity for read-across. J ChemInform 6:39. https://doi.org/10.1186/s13321-014-0039-1
Willett P, Barnard JM, Downs GM (1998) Chemical Similarity Searching. J Chem Inf Comput Sci 38:983–996. https://doi.org/10.1021/ci9800211
Blackburn K, Stuard SB (2014) A framework to facilitate consistent characterization of read across uncertainty. Regul Toxicol Pharmacol 68:353–362. https://doi.org/10.1016/j.yrtph.2014.01.004
Patlewicz G, Ball N, Booth ED et al (2013) Use of category approaches, read-across and (Q)SAR: general considerations. Regul Toxicol Pharmacol 67:1–12. https://doi.org/10.1016/j.yrtph.2013.06.002
Wu S, Blackburn K, Amburgey J et al (2010) A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. Regul Toxicol Pharmacol 56:67–81. https://doi.org/10.1016/j.yrtph.2009.09.006
OECD (2017) Guidance on grouping of chemicals, Second edition. OECD, Paris
European Chemicals Agency (2017) Guidance on information requirements and chemical safety assessment chapter R.7b: endpoint specific guidance
Baldi P, Brunak S, Bach F (2001) Bioinformatics: the machine learning approach. MIT press
Lavecchia A (2015) Machine-learning approaches in drug discovery: methods and applications. Drug Discov Today 20:318–331. https://doi.org/10.1016/j.drudis.2014.10.012
Marchant CA (2012) Computational toxicology: a tool for all industries: computational toxicology. Wiley Interdiscip Rev Comput Mol Sci 2:424–434. https://doi.org/10.1002/wcms.100
Michie D (1968) “Memo” functions and machine learning. Nature 218.5136:19
Trisciuzzi D, Alberga D, Mansouri K et al (2015) Docking-based classification models for exploratory toxicology studies on high-quality estrogenic experimental data. Future Med Chem 7:1921–1936. https://doi.org/10.4155/fmc.15.103
Trisciuzzi D, Alberga D, Mansouri K et al (2017) Predictive structure-based toxicology approaches to assess the androgenic potential of chemicals. J Chem Inf Model 57:2874–2884. https://doi.org/10.1021/acs.jcim.7b00420
Kamel M, Ahmed A, Aleksandra R et al (2016) CERAPP: collaborative estrogen receptor activity prediction project. Environ Health Perspect 124:1023–1033. https://doi.org/10.1289/ehp.1510267
Trisciuzzi D, Alberga D, Leonetti F et al (2018) Molecular docking for predictive toxicology. In: Nicolotti O (ed) Computational toxicology. Springer New York, New York, pp 181–197
Martin TM, Harten P, Venkatapathy R et al (2008) A hierarchical clustering methodology for the estimation of toxicity. Toxicol Mech Methods 18:251–266. https://doi.org/10.1080/15376510701857353
US EPA O (2015) Ecotoxicology database. In: US EPA. https://www.epa.gov/chemical-research/ecotoxicology-database. Accessed 29 May 2019
Dimitrov S, Dimitrova N, Parkerton T et al (2005) Base-line model for identifying the bioaccumulation potential of chemicals. SAR QSAR Environ Res 16:531–554. https://doi.org/10.1080/10659360500474623
A review of bioconcentration factor (BCF) and bioaccumulation factor (BAF) assessments for organic chemicals in aquatic organisms - Environmental Reviews. https://www.nrcresearchpress.com/doi/abs/10.1139/a06-005#.XO5Rq4gzbIU. Accessed 29 May 2019
Zhao C, Boriani E, Chana A et al (2008) A new hybrid system of QSAR models for predicting bioconcentration factors (BCF). Chemosphere 73:1701–1707. https://doi.org/10.1016/j.chemosphere.2008.09.033
Benfenati E (2010) The CAESAR project for in silico models for the REACH legislation. Chem Cent J 4:I1. https://doi.org/10.1186/1752-153X-4-S1-I1
Commission E (2006) Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Off J 3961 30122006
Williams ES, Panko J, Paustenbach DJ (2009) The European Union’s REACH regulation: a review of its history and requirements. Crit Rev Toxicol 39:553–575. https://doi.org/10.1080/10408440903036056
Golbamaki A, Cassano A, Lombardo A et al (2014) Comparison of in silico models for prediction of Daphnia magna acute toxicity. SAR QSAR Environ Res 25:673–694. https://doi.org/10.1080/1062936X.2014.923041
Yordanova D, Schultz TW, Kuseva C et al (2019) Automated and standardized workflows in the OECD QSAR toolbox. Comput Toxicol 10:89–104. https://doi.org/10.1016/j.comtox.2019.01.006
Enoch S j. (2010) Chemical category formation and read-across for the prediction of toxicity. In: Puzyn T, Leszczynski J, Cronin MT (eds) Recent advances in QSAR studies. Springer Netherlands, Dordrecht, pp 209–219
Devillers J (2013) Methods for building QSARs. In: Reisfeld B, Mayeno AN (eds) Computational toxicology: Volume II. Humana Press, Totowa, pp 3–27
Klimisch H-J, Andreae M, Tillmann U (1997) A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol 25:1–5. https://doi.org/10.1006/rtph.1996.1076
Gadaleta D, Mangiatordi GF, Catto M et al (2016) Applicability domain for QSAR models: where theory meets reality. Int J Quant Struct-Prop Relatsh IJQSPR 1:45–63. https://doi.org/10.4018/IJQSPR.2016010102
Walker J, Carlsen L, Jaworska J (2003) Improving opportunities for regulatory acceptance of QSARs: the importance of model domain, uncertainty, validity and predictability. QSAR Comb Sci 22:346–350. https://doi.org/10.1002/qsar.200390024
Russom CL, Breton RL, Walker JD, Bradbury SP (2003) An overview of the use of quantitative structure–activity relationships for ranking and prioritizing large chemical inventories for environmental risk assessments. Environ Toxicol Chem 22:1810. https://doi.org/10.1897/01-194
Eriksson L, Jaworska J, Worth AP et al (2003) Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ Health Perspect 111:1361–1375. https://doi.org/10.1289/ehp.5758
Roncaglioni A, Toropov AA, Toropova AP, Benfenati E (2013) In silico methods to predict drug toxicity. Curr Opin Pharmacol 13:802–806. https://doi.org/10.1016/j.coph.2013.06.001
Helma C (2005) Predictive toxicology. CRC Press, Boca Raton, Florida, USA
Judson R (2010) Public databases supporting computational toxicology. J Toxicol Environ Health Part B 13:218–231. https://doi.org/10.1080/10937404.2010.483937
Atkins D (2003) Revolutionizing science and engineering through cyberinfrastructure: report of the National Science Foundation Blue-Ribbon Advisory Panel on Cyberinfrastructure
Judson PN, Cooke PA, Doerrer NG et al (2005) Towards the creation of an international toxicology information Centre. Toxicology 213:117–128. https://doi.org/10.1016/j.tox.2005.05.014
Heidorn CJA, Rasmussen K, Hansen BG et al (2003) IUCLID: an information management tool for existing chemicals and biocides. J Chem Inf Comput Sci 43:779–786. https://doi.org/10.1021/ci0202786
Louis KS, Jones LM, Campbell EG (2002) Macroscope: sharing in science. Am Sci 90:304–307
Hilgartner S, Brandt-Rauf SI (1994) Data access, ownership, and control: toward empirical studies of access practices. Knowledge 15:355–372. https://doi.org/10.1177/107554709401500401
Staples CA, Woodburn K, Caspers N et al (2002) A weight of evidence approach to the aquatic hazard assessment of bisphenoi A. Hum Ecol Risk Assess Int J 8:1083–1105. https://doi.org/10.1080/1080-700291905837
Benedetti M, Ciaprini F, Piva F et al (2012) A multidisciplinary weight of evidence approach for classifying polluted sediments: integrating sediment chemistry, bioavailability, biomarkers responses and bioassays. Environ Int 38:17–28. https://doi.org/10.1016/j.envint.2011.08.003
Piva F, Ciaprini F, Onorati F et al (2011) Assessing sediment hazard through a weight of evidence approach with bioindicator organisms: a practical model to elaborate data from sediment chemistry, bioavailability, biomarkers and ecotoxicological bioassays. Chemosphere 83:475–485. https://doi.org/10.1016/j.chemosphere.2010.12.064
Hartung T (2009) Food for thought … on in silico methods in toxicology. ALTEX 26:155–166. https://doi.org/10.14573/altex.2009.3.155
Bunn DW (1988) Combining forecasts. Eur J Oper Res 33:223–229. https://doi.org/10.1016/0377-2217(88)90165-8
Clemen RT (1989) Combining forecasts: a review and annotated bibliography. Int J Forecast 5:559–583. https://doi.org/10.1016/0169-2070(89)90012-5
The Combination of Forecasts: Journal of the Operational Research Society: Vol 20, No 4. https://www.tandfonline.com/doi/abs/10.1057/jors.1969.103. Accessed 29 May 2019
Hewitt M, Cronin MTD, Madden JC et al (2007) Consensus QSAR models: do the benefits outweigh the complexity? J Chem Inf Model 47:1460–1468. https://doi.org/10.1021/ci700016d
Votano JR, Parham M, Hall LH et al (2004) Three new consensus QSAR models for the prediction of Ames genotoxicity. Mutagenesis 19:365–377. https://doi.org/10.1093/mutage/geh043
Lewis DF, Bird MG, Jacobs MN (2002) Human carcinogens: an evaluation study via the COMPACT and HazardExpert procedures. Hum Exp Toxicol 21:115–122. https://doi.org/10.1191/0960327102ht233oa
Research C for DE and (2019) M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. In: US Food Drug Adm. http://www.fda.gov/regulatory-information/search-fda-guidance-documents/m7r1-assessment-and-control-dna-reactive-mutagenic-impurities-pharmaceuticals-limit-potential. Accessed 29 May 2019
Müller L, Mauthe RJ, Riley CM et al (2006) A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regul Toxicol Pharmacol 44:198–211. https://doi.org/10.1016/j.yrtph.2005.12.001
Sutter A, Amberg A, Boyer S et al (2013) Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. Regul Toxicol Pharmacol 67:39–52. https://doi.org/10.1016/j.yrtph.2013.05.001
Mattingly Carolyn J, Colby Glenn T, Forrest John N, Boyer James L (2003) The comparative toxicogenomics database (CTD). Environ Health Perspect 111:793–795. https://doi.org/10.1289/ehp.6028
Pence HE, Williams A (2010) ChemSpider: an online chemical information resource. J Chem Educ 87:1123–1124. https://doi.org/10.1021/ed100697w
Gaulton A, Bellis LJ, Bento AP et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100–D1107. https://doi.org/10.1093/nar/gkr777
Richard AM, Williams CR (2002) Distributed structure-searchable toxicity (DSSTox) public database network: a proposal. Mutat Res Mol Mech Mutagen 499:27–52. https://doi.org/10.1016/S0027-5107(01)00289-5
Dedication
To the memory of Michele Montaruli, exceptionally gifted PhD student who has always devoted his life to serving others. To you, Michele, our huge embrace.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Tondo, A.R., Montaruli, M., Mangiatordi, G.F., Nicolotti, O. (2020). Early Prediction of Ecotoxicological Side Effects of Pharmaceutical Impurities Based on Open-Source Non-testing Approaches. In: Roy, K. (eds) Ecotoxicological QSARs. Methods in Pharmacology and Toxicology. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0150-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0150-1_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0149-5
Online ISBN: 978-1-0716-0150-1
eBook Packages: Springer Protocols